Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 1:2021:9965064.
doi: 10.1155/2021/9965064. eCollection 2021.

Effect of Garlic (Allium sativum) Supplementation on Premenstrual Disorders: A Randomized, Double-Blind, Placebo-Controlled Trial

Fatemeh Jafari  1 , Malihe Tabarrai  1 , Alireza Abbassian  1 , Farhad Jafari  2 , Mohammad Hossein Ayati  1
Affiliations

Effect of Garlic (Allium sativum) Supplementation on Premenstrual Disorders: A Randomized, Double-Blind, Placebo-Controlled Trial

Fatemeh Jafari et al. Evid Based Complement Alternat Med. .

Abstract

Background: Premenstrual disorders involve physical, behavioral, and mood variations that affect women of childbearing age and interfere with family relationships, household responsibilities, professional duties, and social activities.

Objectives: Considering the side effects of conventional medications, their use is not recommended except in severe cases of premenstrual disorders. Nowadays, there is a tendency to use traditional and complementary medicine that offers various treatments. The purpose of the current study was to investigate the impacts of garlic as a herbal medicine on the severity of premenstrual symptoms.

Methods: This study was a double-blind, randomized, controlled trial. After identification of participants with moderate-to-severe PMS through the premenstrual symptoms screening tools questionnaire (PSST), they were randomly assigned to placebo (n = 64) or garlic (n = 65) groups. Each participant received one tablet daily for three consecutive cycles and logged the severity of their symptoms in the PSST questionnaire during the intervention period.

Results: There was no significant difference between the two groups in the baseline level of premenstrual symptoms before the intervention. After treatment with garlic for three consecutive cycles, the total score of the severity of premenstrual symptoms significantly (P < 0.001) reduced from 34.09 ± 7.31 to 11.21 ± 7.17. In the placebo group, this score changed from 33.35 ± 7.96 to 24.28 ± 7.22. The difference between mean changes in the two groups was 13.78, with a 95% Confidence Interval (CI) of 11.23-16.33. No serious side effects were observed in either group.

Conclusion: Our findings highlight the potential effect of garlic in reducing the severity of premenstrual symptoms; therefore, the use of garlic can be considered as an alternative therapy in the prevention and treatment of premenstrual disorders.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest regarding the publication of this paper. Dineh Company was not involved in any part of this study from development to manuscript writing.

Figures

Figure 1
Figure 1
Flow diagram of the study.
See this image and copyright information in PMC

References

    1. O’Brien S., Rapkin A., Dennerstein L., Nevatte T. Diagnosis and management of premenstrual disorders. BMJ . 2011;342 doi: 10.1136/bmj.d2994. - DOI - PubMed
    1. O’Brien P. M. S., Bäckström T., Brown C. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Archives of Women’s Mental Health . 2011;14(1):13–21. doi: 10.1007/s00737-010-0201-3. - DOI - PMC - PubMed
    1. Halbreich U., Borenstein J., Pearlstein T., Kahn L. S. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD) Psychoneuroendocrinology . 2003;28:1–23. doi: 10.1016/s0306-4530(03)00098-2. - DOI - PubMed
    1. Pearlstein T. B., Halbreich U., Batzar E. D. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. Journal of Clinical Psychiatry . 2000;61(2):101–109. doi: 10.4088/jcp.v61n0205. - DOI - PubMed
    1. Rapkin A. J., Winer S. A. Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness. Expert Review of Pharmacoeconomics & Outcomes Research . 2009;9(2):157–170. doi: 10.1586/erp.09.14. - DOI - PubMed

LinkOut - more resources